Denosumab ameliorates muscle indices in Chinese osteoporosis patients through clinical and bioinformatic evidence of RANKL in sarcopenia

Summary: This study investigated the effects of denosumab on muscle parameters in Chinese patients with primary osteoporosis and explored potential mechanisms through bioinformatic analyses. In a clinical trial involving 103 patients, 12 months of denosumab treatment significantly improved bone mine...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shaotian Li, Shanshan Hu, Xiaoli Zheng, Xiong Ku, Jingfeng Zou, Andong Zhang, Guqiao Nie, Yiting Liu, Chunhui Tian, Mi Yan, Yilan Yin, Yun Liu, Jingjing Wan, Wei Tan, Wen Peng
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2026-02-01
Edice:	iScience
Témata:	Health sciences
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2589004225027701
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!